310 related articles for article (PubMed ID: 27481051)
1. Structural mutation analysis of PTEN and its genotype-phenotype correlations in endometriosis and cancer.
Smith IN; Briggs JM
Proteins; 2016 Nov; 84(11):1625-1643. PubMed ID: 27481051
[TBL] [Abstract][Full Text] [Related]
2. Dynamics and structural stability effects of germline PTEN mutations associated with cancer versus autism phenotypes.
Smith IN; Thacker S; Jaini R; Eng C
J Biomol Struct Dyn; 2019 Apr; 37(7):1766-1782. PubMed ID: 29663862
[TBL] [Abstract][Full Text] [Related]
3. Mutations in the PTEN tumor gene and risk of endometriosis: a case-control study.
Govatati S; Kodati VL; Deenadayal M; Chakravarty B; Shivaji S; Bhanoori M
Hum Reprod; 2014 Feb; 29(2):324-36. PubMed ID: 24154570
[TBL] [Abstract][Full Text] [Related]
4. Involvement of pelvic inflammation-related mismatch repair abnormalities and microsatellite instability in the malignant transformation of ovarian endometriosis.
Fuseya C; Horiuchi A; Hayashi A; Suzuki A; Miyamoto T; Hayashi T; Shiozawa T
Hum Pathol; 2012 Nov; 43(11):1964-72. PubMed ID: 22626277
[TBL] [Abstract][Full Text] [Related]
5. Loss of heterozygosity on 10q23.3 and mutation of the tumor suppressor gene PTEN in benign endometrial cyst of the ovary: possible sequence progression from benign endometrial cyst to endometrioid carcinoma and clear cell carcinoma of the ovary.
Sato N; Tsunoda H; Nishida M; Morishita Y; Takimoto Y; Kubo T; Noguchi M
Cancer Res; 2000 Dec; 60(24):7052-6. PubMed ID: 11156411
[TBL] [Abstract][Full Text] [Related]
6. [Pathogenic role of PTEN tumor suppressor gene in ovarian cancer associated to endometriosis].
Castiblanco G A; Pires N Y; Wistuba O I; Riquelme S E; Andrade M L; Corvalán R A
Rev Med Chil; 2006 Mar; 134(3):271-8. PubMed ID: 16676097
[TBL] [Abstract][Full Text] [Related]
7. Common genetic changes between endometriosis and ovarian cancer.
Obata K; Hoshiai H
Gynecol Obstet Invest; 2000; 50 Suppl 1():39-43. PubMed ID: 11093060
[TBL] [Abstract][Full Text] [Related]
8. Loss of heterozygosity and mutational analysis of the PTEN/MMAC1 gene in synchronous endometrial and ovarian carcinomas.
Lin WM; Forgacs E; Warshal DP; Yeh IT; Martin JS; Ashfaq R; Muller CY
Clin Cancer Res; 1998 Nov; 4(11):2577-83. PubMed ID: 9829719
[TBL] [Abstract][Full Text] [Related]
9. Phosphatase and Tensin Homolog Is a Potential Target for Ovarian Cancer Sensitization to Cytotoxic Agents.
McCormick A; Earp E; Leeson C; Dixon M; O'Donnell R; Kaufmann A; Edmondson RJ
Int J Gynecol Cancer; 2016 May; 26(4):632-9. PubMed ID: 26905328
[TBL] [Abstract][Full Text] [Related]
10. Possible relevance of tumor-related genes mutation to malignant transformation of endometriosis.
Ma X; Hui Y; Lin L; Wu Y; Zhang X; Qin X
Eur J Gynaecol Oncol; 2016; 37(1):89-94. PubMed ID: 27048117
[TBL] [Abstract][Full Text] [Related]
11. Ovarian and endometrial endometrioid adenocarcinomas have distinct profiles of microsatellite instability, PTEN expression, and ARID1A expression.
Huang HN; Lin MC; Tseng LH; Chiang YC; Lin LI; Lin YF; Huang HY; Kuo KT
Histopathology; 2015 Mar; 66(4):517-28. PubMed ID: 25195947
[TBL] [Abstract][Full Text] [Related]
12. Role of K-ras and Pten in the development of mouse models of endometriosis and endometrioid ovarian cancer.
Dinulescu DM; Ince TA; Quade BJ; Shafer SA; Crowley D; Jacks T
Nat Med; 2005 Jan; 11(1):63-70. PubMed ID: 15619626
[TBL] [Abstract][Full Text] [Related]
13. PTEN sequence analysis in endometrial hyperplasia and endometrial carcinoma in Slovak women.
Gbelcová H; Bakeš P; Priščáková P; Šišovský V; Hojsíková I; Straka Ľ; Konečný M; Markus J; D'Acunto CW; Ruml T; Böhmer D; Danihel Ľ; Repiská V
Anal Cell Pathol (Amst); 2015; 2015():746856. PubMed ID: 26114084
[TBL] [Abstract][Full Text] [Related]
14. Molecular mechanisms and biological plausibility underlying the malignant transformation of endometriosis: a critical analysis.
Viganó P; Somigliana E; Chiodo I; Abbiati A; Vercellini P
Hum Reprod Update; 2006; 12(1):77-89. PubMed ID: 16172112
[TBL] [Abstract][Full Text] [Related]
15. A comprehensive functional analysis of PTEN mutations: implications in tumor- and autism-related syndromes.
Rodríguez-Escudero I; Oliver MD; Andrés-Pons A; Molina M; Cid VJ; Pulido R
Hum Mol Genet; 2011 Nov; 20(21):4132-42. PubMed ID: 21828076
[TBL] [Abstract][Full Text] [Related]
16. A Saturation Mutagenesis Approach to Understanding PTEN Lipid Phosphatase Activity and Genotype-Phenotype Relationships.
Mighell TL; Evans-Dutson S; O'Roak BJ
Am J Hum Genet; 2018 May; 102(5):943-955. PubMed ID: 29706350
[TBL] [Abstract][Full Text] [Related]
17. Biophysical simulations and structure-based modeling of residue interaction networks in the tumor suppressor proteins reveal functional role of cancer mutation hotspots in molecular communication.
Verkhivker GM
Biochim Biophys Acta Gen Subj; 2019 Jan; 1863(1):210-225. PubMed ID: 30339916
[TBL] [Abstract][Full Text] [Related]
18. Clonal Expansion and Diversification of Cancer-Associated Mutations in Endometriosis and Normal Endometrium.
Suda K; Nakaoka H; Yoshihara K; Ishiguro T; Tamura R; Mori Y; Yamawaki K; Adachi S; Takahashi T; Kase H; Tanaka K; Yamamoto T; Motoyama T; Inoue I; Enomoto T
Cell Rep; 2018 Aug; 24(7):1777-1789. PubMed ID: 30110635
[TBL] [Abstract][Full Text] [Related]
19. Cellular, histologic, and molecular changes associated with endometriosis and ovarian cancer.
Siufi Neto J; Kho RM; Siufi DF; Baracat EC; Anderson KS; Abrão MS
J Minim Invasive Gynecol; 2014; 21(1):55-63. PubMed ID: 23962574
[TBL] [Abstract][Full Text] [Related]
20. RUNX3 is inactivated by promoter hypermethylation in malignant transformation of ovarian endometriosis.
Guo C; Ren F; Wang D; Li Y; Liu K; Liu S; Chen P
Oncol Rep; 2014 Dec; 32(6):2580-8. PubMed ID: 25333219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
